Correlation Between Puma Biotechnology and T2 Biosystms

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and T2 Biosystms at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and T2 Biosystms into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and T2 Biosystms, you can compare the effects of market volatilities on Puma Biotechnology and T2 Biosystms and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of T2 Biosystms. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and T2 Biosystms.

Diversification Opportunities for Puma Biotechnology and T2 Biosystms

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Puma and TTOO is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and T2 Biosystms in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on T2 Biosystms and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with T2 Biosystms. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of T2 Biosystms has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and T2 Biosystms go up and down completely randomly.

Pair Corralation between Puma Biotechnology and T2 Biosystms

Given the investment horizon of 90 days Puma Biotechnology is expected to generate 0.55 times more return on investment than T2 Biosystms. However, Puma Biotechnology is 1.81 times less risky than T2 Biosystms. It trades about 0.22 of its potential returns per unit of risk. T2 Biosystms is currently generating about -0.15 per unit of risk. If you would invest  242.00  in Puma Biotechnology on September 16, 2024 and sell it today you would earn a total of  46.00  from holding Puma Biotechnology or generate 19.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Puma Biotechnology  vs.  T2 Biosystms

 Performance 
       Timeline  
Puma Biotechnology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.
T2 Biosystms 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days T2 Biosystms has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Puma Biotechnology and T2 Biosystms Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Puma Biotechnology and T2 Biosystms

The main advantage of trading using opposite Puma Biotechnology and T2 Biosystms positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, T2 Biosystms can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in T2 Biosystms will offset losses from the drop in T2 Biosystms' long position.
The idea behind Puma Biotechnology and T2 Biosystms pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Correlations
Find global opportunities by holding instruments from different markets